Position:
Clinical Assistant Professor
Division:
Neurology
Education:
University of British Columbia, Occupational Therapy , Bachelor of Science
McMaster University, MD
Recent Publications:

•Alotaibi N, Briemberg H.  Evaluation of upper extremity mononeuropathy.  BMJ Point-of-Care  2008; www.pointofcare.bmj.com.
•Burns TM, Conaway MR, Cutter GR, Sanders DB; Muscle Study Group.  Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.  Muscle Nerve. 2008;38(2):957-63.
•Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L; Muscle Study Group.  Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity.  Muscle Nerve. 2008;37(4):473-6.
•Mullins LL, Carpentier MY, Paul RH, Sanders DB; Muscle Study Group.  Disease-specific measure of quality of life for myasthenia gravis.  Muscle Nerve. 2008;38(2):947-56.
•Muscle Study Group.  A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.  Neurology. 2008 ;71(6):394-9.
•Wolfe GI, Barohn RJ, Sanders DB, McDermott MP; Muscle Study Group.  Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis. Muscle Nerve. 2008;38(5): 1429-33.
•Briemberg, HR.  Peripheral nerve complications of medical disease.  Seminars in Neurology 2009:29(2);124-135.
•Qasem A, Tanha F, Briemberg, HR.  Diabetic Muscle Infarction. Can.J.Neurol.Sci. 2009:36;651-653.
•Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, Lonial S, Hassoun H, Avigan DE, Oaklander AL, Kuter DJ, Wen PY, Kesari S, Briemberg, HR, Schlossman RL, Munshi NC, Heffner LT, Doss D, Esseltine DL, Weller E, Anderson KC, Amato AA.  Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.  Journal of Clinical Oncology 2009;27(21):3518-3525.
•Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M, and the Northeast and Canadian Amyotrophic Lateral Sclerosis consortia. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis:  a randomized, double-blind, placebo-controlled trial.  www.thelancet.com/neurology  Published online April 6, 2010.  DOI:10.1016/S1474-4422(10)70068-5.
•Rademakers R, Stewart H, DeJesus-Hernandez M, Krieger C, Graff-Radford n, Fabros M, Briemberg H, Cashman N, Eisen A, Mackenzie I.  FUS gene mutations in familial and sporadic amyotrophic lateral sclerosis.  Muscle Nerve 2010;42(2):170-6.
•Sadjadi R, Rose MR; Muscle Study Group.  What determines quality of life in inclusion body myositis?  J Neurol Neurosurg Psychiatry 2010;81(10):1164-6.